Camostat With Bicalutamide for COVID-19
Clinical trial NCT04652765 · TERMINATED
Trial details
- NCT number
- NCT04652765
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2021-09-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.